APOA1 Antikörper
Kurzübersicht für APOA1 Antikörper (ABIN648690)
Target
Alle APOA1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- Mouse Anti-Human Apolipoprotein AI / APOA1
-
Produktmerkmale
- Cancer-related Markers
-
Aufreinigung
- Purified
-
Reinheit
- >90 % pure, as determined by SDS-PAGE
-
-
anti-Apolipoprotein A-I (APOA1) antibody
APOA1 Reaktivität: Maus WB, IHC, ELISA, IP Wirt: Ziege Polyclonal unconjugated
anti-Apolipoprotein A-I (APOA1) (AA 122-267) antibodyAPOA1 Reaktivität: Human WB, IHC Wirt: Maus Monoclonal C13 unconjugated
anti-Apolipoprotein A-I (APOA1) (AA 25-264) antibodyAPOA1 Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Apolipoprotein A-I (APOA1) (AA 25-265) antibodyAPOA1 Reaktivität: Kaninchen WB, IHC, IP, ICC Wirt: Maus Monoclonal C3 unconjugated
anti-Apolipoprotein A-I (APOA1) (AA 1-267) antibodyAPOA1 Reaktivität: Human WB, ELISA, IP Wirt: Maus Monoclonal S1 unconjugated
anti-Apolipoprotein A-I (APOA1) (AA 1-267) antibodyAPOA1 Reaktivität: Human WB, PLA Wirt: Kaninchen Polyclonal unconjugated
anti-Apolipoprotein A-I (APOA1) (AA 10-37), (N-Term) antibodyAPOA1 Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB15148 unconjugated
anti-Apolipoprotein A-I (APOA1) (AA 10-37) antibodyAPOA1 Reaktivität: Human WB, IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Apolipoprotein A-I (APOA1) antibodyAPOA1 Reaktivität: Maus, Ratte WB, IHC, ELISA, IHC (p), ID Wirt: Kaninchen Polyclonal unconjugated
anti-Apolipoprotein A-I (APOA1) (N-Term) antibodyAPOA1 Reaktivität: Human, Maus, Ratte WB, IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- Specific methodologies have not been tested using this product.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- APOA1 (Apolipoprotein A-I (APOA1))
-
Andere Bezeichnung
- ApolipoproteinAI
-
Pathways
- Regulation of Lipid Metabolism by PPARalpha, Production of Molecular Mediator of Immune Response, Lipid Metabolism
Target
-
